The Pfizer Institute is a research based collaboration between Pfizer Global R&D, the Cambridge Crystallographic Data Centre (CCDC) and two departments of the University of Cambridge; the department of Materials Science and Metallurgy, and the department of Chemistry.
Research interests encompass all aspects of the structure, manufacture and behaviour of solid dosage forms, such as tablets, at all relevant scales of operation and use. Research spans all length scales from modelling the processes of molecular crystallisation through to achieving better powder compaction, tableting, diffusion and release. The purpose of the institute is to provide a focus for strategic research, complementing the on-going work undertaken by Pfizer.
Click here to visit their site